InvestorsHub Logo
Followers 4
Posts 1270
Boards Moderated 0
Alias Born 05/17/2012

Re: smile86 post# 7018

Tuesday, 10/31/2017 9:53:48 AM

Tuesday, October 31, 2017 9:53:48 AM

Post# of 15056
I agree that ANI is a very successful, fast-growing company with fantastic management! Libigel development not really necessary for continued growth.
Your argument against testosterone therapy for women is weak and uninformed. It has taken way too long but the chances of approval for this product have never been better. ANI owns much of the IP for testosterone therapy for women and monetized, it has block buster potential. Read-up my friend!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News